Allergy Therapeutics
AGY.L
#7101
Rank
NZ$0.71 B
Marketcap
$0.15
Share price
2.38%
Change (1 day)
119.05%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -NZ$87.03 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$69.84 Million. In 2024 the company made an earning of -NZ$87.03 Million, an increase over its 2023 earnings that were of -NZ$92.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-NZ$87.03 Million-5.94%
2023-NZ$92.53 Million243.12%
2022-NZ$26.97 Million-403.33%
2021NZ$8.89 M-49.05%
2020NZ$17.44 M82.31%
2019NZ$9.57 M-159.83%
2018-NZ$16 Million255.37%
2017-NZ$4.51 Million-84.22%
2016-NZ$28.53 Million-1678.94%
2015NZ$1.8 M-44.28%
2014NZ$3.24 M129.45%
2013NZ$1.41 M-19.85%
2012NZ$1.76 M-127%
2011-NZ$6.54 Million2044.94%
2010-NZ$0.31 Million-99.08%
2009-NZ$33.08 Million-53.32%
2008-NZ$70.86 Million-21.76%
2007-NZ$90.57 Million351.81%
2006-NZ$20.05 Million230.51%
2005-NZ$6.07 Million-219.33%
2004NZ$5.08 M-58.79%
2003NZ$12.33 M-196.03%
2002-NZ$12.85 Million